Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.FDA approves B. Braun’s Nutrilipid 20% for parenteral nutrition therapy
Nutrilipid 20% is indicated as a source of calories and essential fatty acids for parenteral nutrition and also as a source of essential fatty acids when a deficiency
Nutrilipid 20% is indicated as a source of calories and essential fatty acids for parenteral nutrition and also as a source of essential fatty acids when a deficiency
MigraPure, which is packaged in pre-measured UnitDose sachets, is a doctor-recommended homeopathic formulation of feverfew and ginger that offers highly effective relief of migraine pain and associated symptoms.
Currently, AG-221 is being evaluated in a Phase I clinical trial in patients with advanced hematologic malignancies. Agios chief medical officer Chris Bowden said the company believes this
Under the deal, Allergan paid $67.5m in cash upfront, subject to certain adjustments and holdbacks, and has also agreed to pay up to an aggregate of $295m in
Lesinurad is an investigational agent that inhibits the URAT1 transporter, increasing uric acid excretion and thereby reduces serum uric acid (sUA). The CLEAR1 and CLEAR2 trials studied lesinurad
The company said that the authorized generic version’s formulation is same as the original drug, Eloxatin, for which it holds the original patent. Eloxatin is a platinum-based drug,
The company, which is collaborating with Regeneron Pharmaceuticals on the global development of Eylea, intends for an immediate roll-out with Germany being one of the first launch countries
OS2966 is a first in class therapeutic being evaluated in multiple models of highly aggressive and resistant solid cancers. Glioblastoma is the most common and deadliest primary adult
As part of the deal, Liomont will seek regulatory approval for Flublok in Mexico and initially sell the product manufactured by Protein Sciences. Liomont has also secured rights
The ECG (electrocardiogram) study in healthy volunteers is designed to evaluate the effect of EVK-001 on cardiac ventricular repolarization, specifically the QT-interval. The study will be carried out